
* Case involved Amarin's cardiovascular drug Vascepa

| Indices | Value | Chg | % |
|---|---|---|---|
| FTSE 100 | 10,360.32 | 28.02 | 0.27% |
| FTSE 250 | 23,302.65 | 116.36 | 0.50% |
| FTSE 350 | 5,638.52 | 16.64 | 0.30% |
| FTSE All-Share | 5,576.71 | 16.23 | 0.29% |
| FTSE Small Cap | 7,813.17 | -1.85 | -0.02% |
| Company | Price | Value | Trades |
|---|---|---|---|
| HSBC Holdings (HSBA) | 1,367.00 | £419,621.41k | 43,929 |
| Rolls-Royce (RR.) | 1,263.20 | £216,932.01k | 43,141 |
| BP (BP.) | 544.70 | £155,702.36k | 38,740 |
| Prudential (PRU) | 974.80 | £193,806.30k | 28,345 |
| Rio Tinto (RIO) | 7,847.00 | £180,508.80k | 25,724 |
| Company | Price | Value | Volume |
|---|---|---|---|
| HSBC Holdings (HSBA) | 1,367.00 | £419,621.41k | 30,679,052 |
| Glaxosmithkline (GSK) | 1,902.00 | £242,547.79k | 12,974,263 |
| Rolls-Royce (RR.) | 1,263.20 | £216,932.01k | 22,373,418 |
| Standard Chartered (STAN) | 1,955.50 | £212,959.79k | 11,026,481 |
| Shell (SHEL) | 3,229.50 | £205,361.61k | 6,440,041 |
| Finance Services | 5.05% |
| Software and Computing | 4.93% |
| Medicine and Biotech | 2.65% |
| Medical Services | 2.34% |
| Media | 2.31% |
| Life Insurance | -2.50% |
| Tobacco | -1.62% |
| Telecommunications | -1.51% |
| Industrial Metals | -1.36% |
| Leisure Goods | -1.29% |

UEM is a unique UK listed fund focused on global infrastructure megatrends in emerging markets with an investment objective to provide long-term total return through a flexible investment policy.
Find Out More